Tiba Biotech, a preclinical biopharmaceutical company, has entered into a five-year, multi-million U.S. dollar agreement with the Australian state government of New South Wales to develop next-generation mRNA vaccines against emergency animal diseases that threaten Australia’s livestock industry and domestic food security.
With additional support from the Australian State Government of Queensland, the Australian Federal Department of Agriculture, Fisheries and Forestry, and Meat & Livestock Australia, this partnership is part of a broader Australian Federal and State initiative to…
